BIIB
Drug Manufacturers - General · Healthcare
Board Member
2023-01-01–present
Board Member
Biogen Inc. (BIIB)Equibles does not estimate personal net worth.
Susan K. Langer is recorded as Board Member at Biogen Inc. (BIIB) since January 1, 2023. The newest filing on record that lists Susan K. Langer as Board Member at Biogen Inc. (BIIB) is dated April 28, 2026. Biogen Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Biogen Inc. includes Christopher A. Viehbacher (CEO and Board Member), Caroline D. Dorsa (Chairman), Michael R. McDonnell (CFO) and 7 others.
2023-01-01–present
Last confirmed April 28, 2026
BIIB
Drug Manufacturers - General · Healthcare
Board Member
2023-01-01–present
No call appearances or filed executive changes recorded yet.